Anthropic Undercuts OpenAI with $1 AI Model for Government, While Perplexity Eyes Chrome Purchase for $34.5 Billion

Anthropic has shaken up the AI market by offering its Claude model to all U.S. government agencies for just one dollar each, directly challenging OpenAI’s similar proposal for ChatGPT. Meanwhile, startup Perplexity has stunned the tech world with a $34.5 billion bid to acquire Google Chrome. In healthcare, AI firm Exscientia reported a 33% increase in treatment efficacy for over half of cancer patients. Additionally, OpenAI may soon rival Elon Musk’s Neuralink through a massive investment in brain-interface firm Merge Labs, signaling intensifying competition across sectors powered by artificial intelligence.

Table of Contents

• Today’s Highlights
• Anthropic Undercuts OpenAI
• Perplexity to Buy Chrome?
• AI Enhancements in Cancer Treatment
• Technology Rivalry: OpenAI vs. Neuralink
• Conclusion

Hello everyone!
Welcome to this edition of AI Tech News Today. I’m Aurora, here with my co-host Isabelle. Today is August 13th, 2025, and we have some exciting updates from the world of Artificial Intelligence to share with you.

Today’s Highlights

Anthropic Undercuts OpenAI

Anthropic has made headlines by offering their AI model, Claude, to all branches of the United States Government for just one dollar per agency.

• This move comes right after OpenAI announced a similar offer for its ChatGPT service.
• By providing Claude for Enterprise and Government, Anthropic aims to:
  • Solidify its presence in governmental projects
  • Gain an edge over OpenAI

It appears competition in the AI landscape is heating up!

Perplexity to Buy Chrome?

In a bold move, startup Perplexity has reportedly offered to purchase Google Chrome for $34.5 billion.

• This offer is significantly higher than analysts say Chrome is worth.
• If the deal goes through, Perplexity plans to:
  • Invest $3 billion into Chrome
  • Keep user preferences intact

With Chrome holding an impressive 68% market share among browsers, this deal could reshape the competitive landscape of web browsers.

AI Enhancements in Cancer Treatment

On the healthcare front, a biotech firm called Exscientia has used Artificial Intelligence to enhance cancer treatment control for patients.

• Their new AI system:
  • Analyzes tumor samples
  • Matches them with the most effective treatments
• As a result, patients experience:
  • A 33% longer treatment effectiveness for 54% of patients

This approach shows great potential in making cancer treatments more tailored and efficient.

Technology Rivalry: OpenAI vs. Neuralink

In technology rivalry news, OpenAI and Sam Altman are reportedly engaging in talks to invest in Merge Labs, a brain-computer interface startup that competes with Elon Musk’s Neuralink.

• Merge Labs aims to raise $250 million to:
  • Develop chips connecting computers to human brains
• Meanwhile, Neuralink plans to implant its chips into 20,000 individuals by 2031.

Conclusion

That’s all for today’s AI updates! Stay informed, curious, and engaged as we keep an eye on these exciting developments in the world of Artificial Intelligence.

See you next time!